Marijan Gerenčer

Agricultural and Biological Sciences · Life Sciences

12h-index684citations34works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Animal Disease Management and Epidemiology(5), HIV Research and Treatment(4), Hepatitis B Virus Studies(4), Animal Virus Infections Studies(4), Poxvirus research and outbreaks(4)

Publications34 total

Are the integrin binding motifs within SARS CoV-2 spike protein and MHC class II alleles playing the key role in COVID-19?
Frontiers in Immunology·2023· 5 citedOpen Access
Correction notice
Veterinary Quarterly·2021Open Access
Reproductive immunology in viviparous mammals: evolutionary paradox of interactions among immune mechanisms and autologous or allogeneic gametes and semiallogeneic foetuses
Veterinary Quarterly·2020· 6 citedOpen Access
Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A/H5N1/VN/1203 pandemic influenza vaccine in humans
Vaccine·2010· 27 cited
Nonreplicating Vaccinia Virus Vectors Expressing the H5 Influenza Virus Hemagglutinin Produced in Modified Vero Cells Induce Robust Protection
Journal of Virology·2009· 29 citedOpen Access
Quantitative/distribution patterns of the small intestinal CD6+ T cells and NOS in pigs following specific/nonspecific immunization against colidiarrhea/colienterotoxemia
2008
Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses
Vaccine·2007· 101 citedOpen Access
Expression pattern of CD molecules on avian immune cells induced by caponisation
2007
In vitro and in vivo anti-retroviral activity of the substance purified from the aqueous extract of Chelidonium majus L.
Antiviral Research·2006· 43 cited
A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses
Vaccine·2005· 122 citedOpen Access
The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection
Virology·2005· 80 cited
Identification of HIV-1 protease cleavage site in human C1-inhibitor
Virus Research·2004· 7 cited
Immunogenicity and Safety of Defective Vaccinia Virus Lister: Comparison with Modified Vaccinia Virus Ankara
Journal of Virology·2002· 65 citedOpen Access
In vitro immunogenicity of inactivated Parapoxvirus ovis for lymphocytes from domestic animal species and humans
2000
A candidate OspC Lyme disease vaccine under clinical investigation
Zentralblatt für Bakteriologie·1999· 1 cited
The role of complement and gp120-specific antibodies in virus lysis and CD4+ T cell depletion in HIV-1-infected patients
Microbial Pathogenesis·1998· 10 cited
Natural IgM Antibodies in Baby Rabbit Serum Bind High-Mannose Glycans on HIV Type 1 Glycoprotein 120/160 and Activate Classic Complement Pathway
AIDS Research and Human Retroviruses·1998· 11 cited
Acquired Deficiency of Functional C1-Esterase Inhibitor in HIV Type 1-Infected Patients
AIDS Research and Human Retroviruses·1997· 8 cited
Inhibition of Classical Complement Activation by Sera from HIV-1-Positive Patients
Clinical Immunology and Immunopathology·1996· 5 cited
Immunosuppression of in vivo and in vitro lymphocyte responses in swine induced by Trichinella spiralis or excretory-secretory antigens of the parasite
Veterinary Parasitology·1992· 10 cited
page 1 of 2Next →

Frequent Co-authors

A Kaštelan(9), I. Valpotić(7), Otfried Kistner(6), Brian A. Crowe(6), P Brühl(6), Helga Savidis-Dacho(5), Perry Barrett(5), Falko G. Falkner(4), N Barrett(4), Friedrich Dorner(4), Vitomir Burek(4), Ivica Valpotić(3), Ivan Bašić(3), Hrvoje Valpotić(3), Martin Spruth(2), Leopold Grillberger(2), Manfred Reiter(2), Christa Tauer(2), Wolfgang Mundt(2), Ian Livey(2)